News - Sanofi


Current filters:


Popular Filters

126 to 150 of 304 results

Generics take toll on Sanofi's 1st-qtr sales, with net profit down 33.5%


French drug major Sanofi (Euronext: SAN) today (May 2) reported first-quarter 2013 financial results…


Court rules in novel False Claims Act case where one pharma firm sues another viewed by HP&M lawyer


The US District Court for the Central District of California issued a ruling recently in an unusual,…

AmphastarGenericsLegalLovenoxNorth AmericaPharmaceuticalPricingSanofi

Sanofi's Aubagio delayed onset of clinically definite MS in TOPIC study


French drug major Sanofi (Euronext: SAN) US biotech subsidiary Genzyme announced today positive top-line…


Sanofi says pediatric vaccine Hexyon/Hexacima approved in Europe


The European Commission has approved French drug major Sanofi (Euronext: SAN) subsidiary Sanofi Pasteur's…

EuropeHexacimaHexyonMerck & CoPharmaceuticalRegulationSanofiSanofi PasteurSanofi Pasteur MSDVaccines

Sanofi and PATH launch large-scale production of semi-synthetic artemisinin in Italy


French drug major Sanofi (Euronext: SAN) and non-profit global health organization PATH's Drug Development…

artemisininPharmaceuticalProductionSanofiTropical diseases

Sanofi Pasteur MSD files for EU approval of "Quadrivalent" flu vaccine


Sanofi Pasteur MSD, the joint venture between French drug major Sanofi (Euronext: SAN) vaccines unit…

EuropeMerck & CoPharmaceuticalRegulationSanofiSanofi PasteurSanofi Pasteur MSDVaccines

Merrimack presents encouraging preclinical research with MM-121 in ER-positive breast cancer model


USA-based Merrimack Pharmaceuticals (Nasdaq: MACK) has announced preclinical study results showing that…

Merrimack PharmaceuticalsMM-121OncologyPharmaceuticalResearchSanofi

Sanofi broadens collaboration with Pieris


German independent, clinical-stage biotech firm Pieris AG and French drug major Sanofi (Euronext|: SAN)…

LicensingPharmaceuticalPieris AGResearchSanofi

Sanofi sells US drug rights to Covis; Prices bond issue


Privately held Swiss specialty drug firm Covis Pharma has reached agreement with a USA-based unit of…

Covis PharmaFinancialMergers & AcquisitionsNorth AmericaPharmaceuticalSanofi

Sanofi to invest $75 million in Vietnam facility; views Chinese expansion


French drug major Sanofi (Euronext: SAN) announced the official launch of a construction project for…


Oncodesign in second deal with Sanofi, in the area of tissue protection and repair


Dijon, France-based Oncodesign, a company specializing in drug discovery and providing pharmacological…


Brazil's CAPES joins forces with Sanofi to provide scholarship students with training in research centers abroad


Brazil's Coordination for the Improvement of Higher Education Personnel (CAPES) and French drug major…

PharmaceuticalResearchSanofiSouth America

Growing US uptake of Genzyme's Aubagio at three months post-launch


Some 34% of surveyed US neurologists have prescribed French drug major Sanofi (Euronext: SAN) subsidiary…

AubagioBiotechnologyGenzymeMarkets & MarketingNeurologicalNorth AmericaPharmaceuticalSanofi

AAD conference briefs: Celgene's apremilast; and Sanofi's dupilumab


The European subsidiary of US biotech firm Celgene Corp (Nasdaq: CELG) presented the results from ESTEEM…


US FDA accepts Sanofi's NDA for diabetes drug lixisenatide


The US Food and Drug Administration has accepted for review French drug major Sanofi's (Euronext: SAN)…

DiabeteslixisenatideNorth AmericaPharmaceuticalRegulationSanofiZealand Pharma

Genzyme's eliglustat meets endpoints in Ph III studies for Gaucher disease


US biotech firm Genzyme, a subsidiary if French drug major Sanofi (Euronext: SAN) has released positive…

BiotechnologyeliglustatGenzymePharmaceuticalRare diseasesResearchSanofi

126 to 150 of 304 results

Back to top